Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer

Background: Pancreatic cancer (PC) is a lethal malignancy with an extremely unfavorable 5-year survival rate and a high mortality rate. Glutathione S-transferase mu-3 (GSTM3) has been shown to exert different functions in the progression and development of various cancers, except for PC. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shunda, Yang, Jinshou, Ding, Cheng, Li, Junjie, You, Lei, Dai, Menghua, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485563/
https://www.ncbi.nlm.nih.gov/pubmed/32984010
http://dx.doi.org/10.3389/fonc.2020.01539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485563/
https://www.ncbi.nlm.nih.gov/pubmed/32984010
http://dx.doi.org/10.3389/fonc.2020.01539

Ejemplares similares